AI leader Heartflow enters new era focused on delivering personalized care for CAD patients
It is the beginning of a new era for Heartflow. The California-based medtech company, known for its artificial intelligence (AI)-based cardiac CT evaluations, has launched all new branding to highlight its focus on delivering high-quality tools that help clinicians prevent, diagnose and treat coronary artery disease (CAD).
Heartflow’s AI-powered coronary CT angiography (CCTA) assessments have already been used to help manage more than 400,000 heart patients around the world. Heartflow One, the company’s noninvasive coronary care platform, includes such software solutions as Roadmap Analysis, FFRCT Analysis and Plaque Analysis.
Heartflow says its updated branding shows the company’s renewed commitment to assisting clinicians with every step of the care pathway. Heartflow’s platform not only evaluates CCTA exams for signs of CAD, it also helps guide the management of patients for years to come.
“At Heartflow, we are working toward a new vision to transform coronary artery disease from the leading cause of death to a disease that can be managed for life,” John Farquhar, president and CEO of Heartflow, said in a prepared statement. “With our AI-driven technology, we’re doing more than diagnosing CAD—we’re equipping clinicians with the insights needed to develop personalized treatment plans to provide the best possible care to each patient. We’re excited about the future, where Heartflow is positioned to help physicians identify CAD earlier and guide patients toward a lifetime of better health.”
The new branding will be seen across the board, from Heartflow’s website to its social media channels. These updates were made using feedback from the company’s customers in addition to other stakeholders within the cardiovascular care community.
Heartflow and Cardiovascular Business are collaborating on a new webinar on March 13. Click here for more information.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.